Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Regeneron Pharmaceuticals Inc (REGN)  
$1,051.03 0.17 (0.02%) as of 4:30 Fri 6/28


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 104,690,000
Market Cap: 110.03(B)
Last Volume: 750,617 Avg Vol: 759,306
52 Week Range: $692.45 - $1071.19
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     S&P SMALLCAP 600
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  150
Guru Rank Value     : 6.9
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Regeneron Pharmaceuticals is a biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Co.'s products include: EYLEA (aflibercept) Injection, which is used for the treatment of neovascular age-related macular degeneration, diabetic macular edema, macular edema following retinal vein occlusion, myopic choroidal neovascularization, diabetic retinopathy, and neovascular glaucoma; REGEN-COV, which is used for the treatment of COVID-19; and Kevzara (sarilumab) Solution for Subcutaneous Injection, which is used for the treatment of rheumatoid arthritis.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 192,108 255,165 311,759 469,743
Total Sell Value $188,697,290 $247,812,013 $294,950,701 $405,465,351
Total People Sold 7 14 16 18
Total Sell Transactions 18 43 67 128
End Date 2024-03-31 2023-12-29 2023-06-30 2022-06-30

   
Records found: 1367
  Page 39 of 55  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Brown Michael S Director   –       •      –    2018-08-22 4 S $380.49 $570,735 D/D (1,500) 0     -
   Brown Michael S Director   –       •      –    2018-08-22 4 OE $177.82 $266,730 D/D 1,500 1,500     -
   Ryan Arthur F Director   –       •      –    2018-08-21 4 GD $0.00 $0 D/D 2,500 28,500     -
   Yancopoulos George President and CSO   •       •      –    2018-08-21 4 GA $0.00 $0 I/I 847 487,988     -
   Yancopoulos George President and CSO   •       •      –    2018-08-21 4 GD $0.00 $0 D/D 847 0     -
   Vagelos P Roy Chairman of the Board   •       •      –    2018-08-20 4 D $374.46 $40,442 D/D (108) 399,949     -
   Vagelos P Roy Chairman of the Board   •       •      –    2018-08-20 4 OE $21.25 $4,463 D/D 210 400,057     -
   Yancopoulos George President and CSO   •       •      –    2018-08-03 4 GA $0.00 $0 I/I 101,187 487,141     -
   Yancopoulos George President and CSO   •       •      –    2018-08-03 4 GD $0.00 $0 I/I 101,187 75,036     -
   Goldstein Joseph L Director   –       •      –    2018-08-02 4 AS $380.00 $760,000 D/D (2,000) 12,000     -
   Goldstein Joseph L Director   –       •      –    2018-08-02 4 OE $57.11 $114,220 D/D 2,000 14,000     -
   Yancopoulos George President and CSO   •       •      –    2018-07-24 4 GA $0.00 $0 I/I 299,134 385,954     -
   Yancopoulos George President and CSO   •       •      –    2018-07-24 4 GD $0.00 $0 I/I 299,134 24,643     -
   Vagelos P Roy Chairman of the Board   •       •      –    2018-07-10 4 AS $364.75 $27,420,277 D/D (74,670) 399,847     -
   Vagelos P Roy Chairman of the Board   •       •      –    2018-07-09 4 D $370.52 $29,124,354 D/D (78,604) 474,517     -
   Vagelos P Roy Chairman of the Board   •       •      –    2018-07-09 4 OE $16.80 $2,575,003 D/D 153,274 553,121     -
   Vagelos P Roy Chairman of the Board   •       •      –    2018-07-06 4 GD $0.00 $0 I/I 610 147,934     -
   Goldstein Joseph L Director   –       •      –    2018-07-06 4 AS $370.00 $740,000 D/D (2,000) 12,000     -
   Goldstein Joseph L Director   –       •      –    2018-07-06 4 OE $57.11 $114,220 D/D 2,000 14,000     -
   Goldstein Joseph L Director   –       •      –    2018-07-05 4 AS $360.00 $720,000 D/D (2,000) 12,000     -
   Goldstein Joseph L Director   –       •      –    2018-07-05 4 OE $57.11 $114,220 D/D 2,000 14,000     -
   Vagelos P Roy Chairman of the Board   •       •      –    2018-06-21 4 AS $323.97 $24,495,410 D/D (74,710) 399,847     -
   Vagelos P Roy Chairman of the Board   •       •      –    2018-06-20 4 D $333.07 $26,167,311 D/D (78,564) 474,557     -
   Vagelos P Roy Chairman of the Board   •       •      –    2018-06-20 4 OE $16.80 $2,575,003 D/D 153,274 553,121     -
   Sanofi-Aventis   •       •       •   2018-06-08 4 S $309.31 $37,611,882 I/I (121,601) 23,758,936     -
  1367 Records found
  Previous  30  31  32  33  34  35  36  37  38  39  Next   
  Page 39 of 55
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us